Test Price
2,800 AED✅ Home Collection Available
RBCK1 Gene Polyglucosan Body Myopathy Type 1 (PGBM1) – Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
التحليل الجيني لجين RBCK1 لاعتلال العضلات متعدد السكريات من النوع 1 في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary
This definitive Next‑Generation Sequencing (NGS) test analyses the entire coding region of the RBCK1 gene to detect pathogenic variants causing Polyglucosan Body Myopathy Type 1, with or without primary immunodeficiency. Our ISO‑certified, DHA‑licensed laboratory delivers 99.9% diagnostic sensitivity, expert genetic counselling, and results in 3–4 weeks, fully aligned with 2026 UAE healthcare regulations.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity through ISO 9001:2015 accredited processing.
- Premium Logistics: Paid hospital‑grade home collection via ISO‑certified cold‑chain and VIP mobile phlebotomy.
- Clinical Guidance: Complimentary telephonic post‑test result interpretation and clinical counselling.
- Insurance: Direct billing verification via WhatsApp +971 54 548 8731.
الملخص التنفيذي: تقدّم مختبراتنا المعتمدة من هيئة الصحة بدبي تحليل جين RBCK1 بتقنية التسلسل من الجيل التالي لتشخيص اعتلال العضلات متعدد السكريات من النوع 1 مع أو بدون نقص المناعة، مع ضمان خصوصية البيانات وحماية القاصرين وفقاً للمرسوم بقانون اتحادي رقم 41 لسنة 2024 وقانون حماية البيانات الشخصية في دولة الإمارات، وشهادة الآيزو 9001:2015.
Test Overview
The RBCK1 genetic analysis is a high‑precision NGS assay that identifies pathogenic mutations in the RBCK1 gene responsible for polyglucosan body myopathy type 1, a rare neuromuscular disorder frequently associated with primary immunodeficiency. Our DHA‑licensed facility processes minimally invasive DNA samples and guarantees results within 3–4 weeks, complemented by mandatory genetic counselling for accurate clinical correlation. نظرة عامة: فحص جيني متطور يعتمد التسلسل من الجيل التالي، مصمم لتشخيص دقيق وعلاج موجّه.
| Feature | Our RBCK1 NGS Test | Closest Alternative |
|---|---|---|
| Precision | Full gene sequencing (99.9% sensitivity) | Single variant or hotspot analysis only |
| Method | NGS (Next‑Generation Sequencing) | Sanger sequencing or targeted PCR |
| Speed | 3–4 weeks | 6–8 weeks |
Physician Insight & Safety Protocol
“As a clinical neurologist, I emphasize that this genetic test provides crucial diagnostic information but must be interpreted within the complete clinical context. All results should be reviewed by your treating physician, alongside your personal and family history, to guide appropriate treatment and surveillance.”
— Dr. Prabhakar Reddy, DHA License: 61713011
Do not discontinue prescribed medication without consulting your doctor.
Exclusion Criteria & Emergency Red Flags
Exclusion Criteria: Home phlebotomy is contraindicated in haemodynamically unstable or critically ill patients; all samples must be collected under strict aseptic conditions. This test is not suitable for non‑medical genetic curiosity; a physician referral is mandatory.
Emergency Red Flags: Seek immediate emergency care if you develop sudden muscle weakness, breathing difficulty, high fever, or confusion. Inform the emergency team of your underlying genetic condition and the pending/completed RBCK1 test.
Patient FAQ & Clinical Guidance
What is the RBCK1 gene test and why is it done?
The RBCK1 gene test is a DNA analysis that detects pathological mutations causing Polyglucosan Body Myopathy Type 1, a rare genetic disorder that weakens muscles and may impair the immune system.
تحليل جين RBCK1 هو اختبار الحمض النووي الذي يكشف عن الطفرات المسببة لاعتلال العضلات متعدد السكريات من النوع 1 مع أو بدون نقص المناعة.
This test is ordered when clinical symptoms, family history, or preliminary investigations point to RBCK1‑related myopathy. It confirms the diagnosis, guides treatment decisions, and enables genetic counselling for family members.
How is the sample collected and how long do results take?
A small blood sample, extracted DNA, or a drop of blood on an FTA card is collected at home by a certified phlebotomist; results are ready in 3 to 4 weeks.
يتم جمع العينة عن طريق سحب الدم بواسطة مختص في المنزل، وتظهر النتائج خلال 3 إلى 4 أسابيع.
The VIP mobile phlebotomy team follows strict cold‑chain and antiseptic protocols. Whole blood, extracted DNA, or dried blood spot on an FTA card are acceptable samples. Turnaround time is guaranteed at 3–4 weeks from the day the specimen reaches our laboratory.
Is this covered by insurance and what do I need for the procedure?
We offer direct billing verification via WhatsApp; you need a physician referral, a completed consent form, and a genetic counselling session to map your family pedigree.
نقدم التحقق المباشر من التأمين عبر واتساب، ويتطلب الإجراء إحالة طبية وجلسة استشارة وراثية.
Before sample collection, you must attend a genetic counselling session with our certified counsellor to draw a detailed pedigree chart of affected family members. We directly verify insurance coverage via WhatsApp (+971 54 548 8731) and can assist with direct billing, ensuring a smooth, compliant process under UAE Federal Decree‑Law No. 41 of 2024.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians